comparing glp-1 agonists Ozempic, Wegovy and Other Drugs GLP-1 Receptor Agonist Market Size

The online pharmacies segment is expected to witness lucrative growth during the predicted timeframe owing to the increased availability of utilization of online platforms and applications providing essential medical delivery services to patients at their doorstep

In addition, some studies on recently marketed GLP-1 RAs such as dulaglutide (AWARD studies), albiglutide (HARMONY studies), and lixisenatide (GetGoal studies) included cardiovascular parameters as a part of their non-primary endpoints (Table 2)

These side effects typically occur during the initiation of the medication or during dose escalation

Quick Answer: Current evidence suggests a possible association between semaglutide and pancreatitis rather than a confirmed causal relationship, with clinical trials showing relatively low incidence rates